Overview

A Bioequivalence Study of Two Ibuprofen Arginine Granules 400 mg Formulations Under Fasting and Fed Conditions in Chinese Healthy Adult Subjects

Status:
Not yet recruiting

Trial end date:
2023-06-27

Target enrollment:

Participant gender:

Summary

The primary purpose of this study is to demonstrate the bioequivalence of two ibuprofen arginine granules 400 milligram (mg) formulations under fasting and fed conditions in Chinese healthy adult participants. The secondary purpose of this study is to assess the pharmacokinetic and safety profile of the test and reference preparations.

Phase:

Phase 1

Details

Lead Sponsor:

HALEON

Treatments:

Ibuprofen
Ibuprofen arginine